TickerTain
$SPCX····$NVDA····$MSFT····$GOOGL····$ANTHROPIC·$TSLA····$CRWV····$NBIS····$HIMS····$TSM····$ASML····$FIGURE·$LYFT····$UBER····$SNOW····$META····$ELEVENLABS·$CURSOR·$COGNITION·$OPENAI·$AAPL····$RKLB····$XAI·$AMZN····$AMD····$000660.KS····$INTC····
← newsroom
$HIMS · Hims & Hers Just Got a LOT Bigger! | $HIMS
now playing · $HIMS
$HIMS···bullish· high· postravis hoium
Hims & Hers closes Eucalyptus acquisition to accelerate healthcare aggregator strategy
The Eucalyptus acquisition adds ~$450M revenue (19% growth) and 750K+ customers, expanding Hims & Hers into Australia, Japan, and Europe; combined with GLP-1 partnerships with Nov…
$ZAVAneutral· lowtravis hoium
Zava acquisition gave Hims & Hers initial European foothold
Zava was Hims & Hers' first major acquisition, a European-based company that added several countries to their addressable market, setting the stage for the larger Eucalyptus deal.
$EUCALYPTUSbullish· mediumtravis hoium
Eucalyptus adds $450M revenue and Australian/Japan exposure to Hims & Hers
Eucalyptus brings a $450M+ annual revenue run rate, 750K+ served customers, and triple-digit growth in 2025, giving Hims & Hers immediate scale in Australia, Japan, UK, Germany, a…